Zoetis hives off 3 manufacturing plants in deal with Bulgarian drugmaker

Tracy Staton Zoetis, under pressure from investors to shape up, laid out a sweeping plan earlier this year to eliminate 10 plants and about 2,500 jobs as part of an effort ...

Zoetis agrees on $765M deal for aquaculture leader Pharmaq

Carly Helfand Animal health leader Zoetis–which has been the subject of many a pharma buyout rumor–is making a pickup of its own. Late Monday, the Pfizer spinoff announced ...

Valeant makes offer for Zoetis, sources tell WSJ

Eric Palmer Rapidly expanding Valeant has approached Zoetis about a buyout, sources told the Wall Street Journal. Rumors of a possible deal, which have been bouncing back and forth ...

Zoetis, under pressure from activist investor Ackman, will offload 10 plants to cut costs

Eric Palmer Animal health leader Zoetis is using a move out of the Amgen playbook, whacking on manufacturing to cut costs and appease an aggressive activist investor. FiercePharma News

Breaking up with Pfizer is hard to do, Zoetis chief says, but worth it

Tracy Staton Why do Russians prefer cats to dogs? Which livestock drugs are growing fastest? And what are the benefits of being separate from Pfizer? FiercePharma News

Pfizer offers share exchange to grant Zoetis its freedom

Tracy Staton Pfizer is cutting the apron strings at Zoetis. Just months after its highly successful IPO, in which Pfizer sold off a 20% stake, the animal health business is set to become ...

AbbVie, Pfizer’s Zoetis deals ignite enormous leap in M&A value

Eric Palmer Pfizer's spinoff of its animal health business into Zoetis is the biggest IPO this year. And the spinoff that created the newest Big Pharma company, AbbVie, was no slouch. FiercePharma ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS